Pigmentation Disorders Treatment Market Is Estimated To Witness High Growth
Pigmentation disorders refer to conditions that result in hyperpigmentation or hypopigmentation of the skin. Some common types of pigmentation disorders include melasma, post-inflammatory hyperpigmentation, vitiligo, freckles and age spots. Treatment for pigmentation disorders involves the use of topical drugs or therapies such as hydroquinone, retinoids, corticosteroids, phenylethyl resorcinol, and laser therapy. These products help in inhibiting the production of melanin in the skin or speed up the skin cell turnover process to lighten hyperpigmentation spots. The rising prevalence of skin diseases like vitiligo and melasma is fueling the demand for effective pigmentation disorder treatments.
The global Pigmentation Disorders Treatment Market is estimated to be valued at US$ 6.84 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The rising prevalence of skin diseases represents a major market opportunity for players in the pigmentation disorders treatment market. According to the Vitiligo Support International, vitiligo affects approximately 0.5-2% of the total population. Meanwhile, the prevalence of melasma is approximately 3-5% in the American population and 10-15% globally. The exact causes of these conditions are still unknown, however, genetic factors, autoimmune disorders andenvironmental triggers like sun exposure are known contributors. The high and growing incidence of vitiligo and melasma presents a large patient pool requiring treatment. This offers significant opportunity for pharmaceutical companies to develop advanced and effective drugs to cater to this growing demand.
Porter's Analysis
Threat of new entrants: The pigmentation disorders treatment market requires large investments in R&D for drug development. Companies need strong intellectual property rights to protect new products which reduces threat of new entrants.
Bargaining power of buyers: The presence of many established brands leads to intense competition and offers buyers more treatment options. This strengthens their bargaining power.
Bargaining power of suppliers: Key active pharmaceutical ingredients and raw material suppliers have some bargaining power due to specialized expertise required. However, availability of substitutes limits their influence on prices.
Threat of new substitutes: Threat from new substitutes is moderate as treatments from other disease areas do not completely replace those for pigmentation disorders. However, adjacent markets pose competition.
Competitive rivalry: The market sees strong competition due to many global and local players offering similar products. Pricing pressure exists due to differential pricing across regions.
SWOT Analysis
Strengths: Growing awareness, rising skin concerns, increasing research funding, new product development
Weaknesses: High R&D costs, patent cliffs of blockbuster drugs, stringent regulations
Opportunities: Untapped emerging markets, expanding indications of approved drugs, combination therapies
Threats: Side effects of medications, social stigma in some regions, substitutes from other therapeutic areas
Key Takeaways
The Global Pigmentation Disorders Treatment Market Growth is expected to witness high over the forecast period of 2023 to 2030 supported by increasing awareness, growing cosmetic procedures, rising healthcare expenditure in emerging nations.
Regional analysis- North America region currently dominates the global market owing to high healthcare spending and favorable reimbursement policies in the US and Canada for new drug approvals. Asia Pacific region is poised to grow at the fastest pace during the forecast period due to large patient pool, rising affordability, and expanding healthcare infrastructure in countries such as China and India.
Key players operating in the pigmentation disorders treatment market are Hyundai Heavy Industries, Daewoo Shipbuilding & Marine Engineering, China State Shipbuilding Corporation, Mitsubishi Heavy Industries, Samsung Heavy Industries, Imabari Shipbuilding Co., Ltd., Tsuneishi Group, China Shipbuilding Industry Corporation, General Dynamics Corporation, Fincantieri S.p.A., Meyer Werft GmbH & Co. KG, Navantia, Damen Shipyards Group, STX Offshore & Shipbuilding Co., Ltd., Kawasaki Heavy Industries.
Explore more information on this topic, Please visit -